000 01425 a2200409 4500
005 20250515135155.0
264 0 _c20090224
008 200902s 0 0 eng d
022 _a1525-6049
024 7 _a10.1080/08860220802248977
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMolina, Manuel
245 0 0 _aChange in darbepoetin alfa administration schedule affects erythropoiesis-stimulating agent resistance in patients with chronic kidney disease receiving hemodialysis.
_h[electronic resource]
260 _bRenal failure
_c2008
300 _a778-83 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnemia
_xdrug therapy
650 0 4 _aDarbepoetin alfa
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Resistance
650 0 4 _aErythropoietin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHematinics
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xcomplications
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aRenal Dialysis
700 1 _aNavarro, Maria Jose
700 1 _ade Gracia, Carmen
700 1 _aAlvarez, Gracia
700 1 _ade Alarcon, Rosa
700 1 _aGarcia, Maria Angeles
773 0 _tRenal failure
_gvol. 30
_gno. 8
_gp. 778-83
856 4 0 _uhttps://doi.org/10.1080/08860220802248977
_zAvailable from publisher's website
999 _c18260388
_d18260388